If you recall in 2022, Bioventus planned to acquire CartiHeal for $450M (4X sales), but Bioventus spit them out - "Not so fast… Bioventus backs out of CartiHeal acquisition for $450M (4.5 X sales)"
Key Milestones in CartiHeal's History
2004: CartiHeal is founded
2012: CartiHeal initiates clinical trials for Agili-C™
2016: CartiHeal receives CE Mark approval for Agili-C™
2020: CartiHeal receives FDA Breakthrough Device Designation for Agili-C™
2022: CartiHeal receives FDA Premarket Approval (PMA) for Agili-C™
2022
Press Release
November 22, 2023 – Smith+Nephew (LSE:SN, N...
